These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7507097)

  • 1. Technology briefs from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). Diathermy and balloon dialatation treatment of benign prostatic hypertrophy.
    Int J Technol Assess Health Care; 1993; 9(4):593-5. PubMed ID: 7507097
    [No Abstract]   [Full Text] [Related]  

  • 2. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). Percutaneous transluminal coronary angioplasty: update of application and standards for utilization.
    Int J Technol Assess Health Care; 1997; 13(4):646-7. PubMed ID: 9527533
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from the Conseil d'Evaluation des Technologies de la Santé (CETS). Mandate of the conseil.
    Int J Technol Assess Health Care; 1992; 8(2):366. PubMed ID: 1628918
    [No Abstract]   [Full Text] [Related]  

  • 4. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). The safety of dental amalgam: a state-of-the-art review.
    Int J Technol Assess Health Care; 1997; 13(4):639-42. PubMed ID: 9489256
    [No Abstract]   [Full Text] [Related]  

  • 5. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). The cochlear implant in adults, adolescents, and children.
    Int J Technol Assess Health Care; 1997; 13(4):642-5. PubMed ID: 9527532
    [No Abstract]   [Full Text] [Related]  

  • 6. Reports from the Conseil d'évaluation des Technologies de la Santé du Québec. Hemodialyzer reuse: considerations of safety and cost.
    Int J Technol Assess Health Care; 1991; 7(4):639-40. PubMed ID: 1778710
    [No Abstract]   [Full Text] [Related]  

  • 7. Report from the Conseil D'Evaluation des Technologies de la Santé du Québec (CETS). The costs of conventional cholecystectomy, laparoscopic cholecystectomy, and biliary lithotripsy.
    Int J Technol Assess Health Care; 1994; 10(4):713. PubMed ID: 7843893
    [No Abstract]   [Full Text] [Related]  

  • 8. Report from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS).
    Int J Technol Assess Health Care; 1995; 11(3):629-31. PubMed ID: 7591561
    [No Abstract]   [Full Text] [Related]  

  • 9. Reports from the Conseil d'evaluation des technologies de la santé du Quebec.
    Int J Technol Assess Health Care; 1994; 10(1):198-200. PubMed ID: 8157454
    [No Abstract]   [Full Text] [Related]  

  • 10. Reports from the Conseil D'évaluation des Technologies de la Santé du Québec. Screening for breast cancer in Quebec: estimates of health effects and costs.
    Int J Technol Assess Health Care; 1991; 7(4):638-9. PubMed ID: 1778709
    [No Abstract]   [Full Text] [Related]  

  • 11. Can our health services be saved by technology evaluation? The Quebec experience.
    McGregor M
    Clin Invest Med; 1994 Aug; 17(4):334-42. PubMed ID: 7982297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedical research in Quebec: the history of the Fonds de la recherche en santé du Québec.
    Genest J
    CMAJ; 1996 Sep; 155(6):639-44. PubMed ID: 8823209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reuse of single-use cardiac catheters: safety, economical, ethical and legal issues. Conseil d'évaluation des technologies de la sante du Québec.
    Can J Cardiol; 1994 May; 10(4):413-21. PubMed ID: 8193985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reports from the British Columbia Office of Health Technology Assessment (BCOHTA). Incorporating clinical effectiveness debates into hospital technology assessment: the case of laser treatment of benign prostatic hyperplasia.
    Int J Technol Assess Health Care; 1997; 13(4):937-9. PubMed ID: 9527534
    [No Abstract]   [Full Text] [Related]  

  • 15. [New technologies in the treatment of benign prostatic hyperplasia].
    Trapeznikova MF; Bazaev VV; Mezentsev VA
    Urol Nefrol (Mosk); 1996; (4):41-7. PubMed ID: 8928351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transurethral balloon dilatation in benign prostatic hypertrophy].
    Gillon G; Servadio C
    Harefuah; 1991 Jun; 120(12):748-50. PubMed ID: 1720409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the evaluation and treatment of benign prostatic hypertrophy].
    Wabrosch G; Vanik M
    Orv Hetil; 1993 Oct; 134(44):2411-6. PubMed ID: 7694220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of orphans and balloons.
    McGivney WT
    Physician Exec; 1991; 17(5):41-3. PubMed ID: 10114721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive therapy in bladder outflow obstruction due to benign prostatic hypertrophy. A review of prostatic balloon dilatation and stenting.
    Jäger HR; Adam A
    Ann Chir Gynaecol; 1993; 82(2):134-40. PubMed ID: 7689316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Benign prostatic hyperplasia: prostatectomy and alternatives].
    Sulser T
    Ther Umsch; 1995 Jun; 52(6):383-92. PubMed ID: 7541567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.